Nonetheless, in recent years, FLT3 has emerged as a significant marker for enhancing the biological characterization of patients with ALL, particularly within specific subtypes such as Ph-like and r-KMT2A ALL (31, 32, 44, 53, 56). The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.